Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Current Assets (2016 - 2025)

Angiodynamics (ANGO) has disclosed Current Assets for 15 consecutive years, with $161.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets changed N/A year-over-year to $161.3 million, compared with a TTM value of $161.3 million through Nov 2025, changed N/A, and an annual FY2025 reading of $168.3 million, changed N/A over the prior year.
  • Current Assets was $161.3 million for Q4 2025 at Angiodynamics, up from $156.7 million in the prior quarter.
  • Across five years, Current Assets topped out at $196.9 million in Q1 2024 and bottomed at $127.7 million in Q1 2022.
  • Average Current Assets over 5 years is $157.6 million, with a median of $157.7 million recorded in 2022.
  • The sharpest move saw Current Assets rose 29.06% in 2024, then dropped 12.51% in 2025.
  • Year by year, Current Assets stood at $132.2 million in 2021, then rose by 20.16% to $158.8 million in 2022, then rose by 16.77% to $185.5 million in 2023, then decreased by 6.94% to $172.6 million in 2024, then fell by 6.52% to $161.3 million in 2025.
  • Business Quant data shows Current Assets for ANGO at $161.3 million in Q4 2025, $156.7 million in Q3 2025, and $168.3 million in Q2 2025.